Evaluation status available after sign-in
About the journal
Pharmacoepidemiology is an open-access journal published by MDPI AG in Switzerland, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,000 CHF. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- MDPI AG
- ISSN
- 2813-0618
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,000 CHF
- Articles in DOAJ
- 105
- Declared review time
- 6 weeks
- Declared peer-review model
- other
- Official website
- https://www.mdpi.com/journal/pharmacoepidemiology
Index listings
- DOAJ · 2023-03-27
- Indexing
- DOAJ
- APC
- 1,000 CHF
- Declared review time (DOAJ)
- 6 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
105
Most recent article
4 months ago
Average review time (journal-declared via DOAJ)
6weeks
Works in OpenAlex
351
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
31
i10-index
72
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2023-03-27
- Added to DOAJ
- 2023-03-27
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSS
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 96%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity1
- Source type
- journal
Classification6
Subjects (DOAJ)
Medicine: Therapeutics. PharmacologyMedicine: Other systems of medicineMedicine: Public aspects of medicine
LCC codes
RM1-950RZ201-999RA1-1270
Subject areas
- Pharmacovigilance and Adverse Drug Reactions
- Pharmacovigilance and Adverse Drug Reactions
- Pharmacovigilance and Adverse Drug Reactions
- Pharmaceutical Practices and Patient Outcomes
- Statistical Methods in Clinical Trials
- Statistical Methods in Clinical Trials
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical Practices and Patient Outcomes
Show all subjects (75)
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Statistical Methods in Epidemiology
- Statistical Methods in Clinical Trials
- Pharmaceutical industry and healthcare
- Pharmaceutical studies and practices
- Pharmaceutical studies and practices
- Pharmacy and Medical Practices
- Pharmaceutical Economics and Policy
- Medical Coding and Health Information
- Pharmaceutical Economics and Policy
- Pharmaceutical Economics and Policy
- Advanced Causal Inference Techniques
- Data-Driven Disease Surveillance
- Electronic Health Records Systems
- Pharmaceutical studies and practices
- Health Systems, Economic Evaluations, Quality of Life
- Antibiotic Use and Resistance
- Opioid Use Disorder Treatment
- Advanced Causal Inference Techniques
- Advanced Causal Inference Techniques
- Antibiotic Use and Resistance
- Healthcare Policy and Management
- Antibiotic Use and Resistance
- Meta-analysis and systematic reviews
- Meta-analysis and systematic reviews
- Medication Adherence and Compliance
- Pharmacogenetics and Drug Metabolism
- Pharmaceutical industry and healthcare
- Medication Adherence and Compliance
- Pharmaceutical industry and healthcare
- Pharmacogenetics and Drug Metabolism
- Patient Safety and Medication Errors
- Meta-analysis and systematic reviews
- Pharmacogenetics and Drug Metabolism
- Opioid Use Disorder Treatment
- Computational Drug Discovery Methods
- Medication Adherence and Compliance
- Pregnancy and Medication Impact
- Computational Drug Discovery Methods
- Opioid Use Disorder Treatment
- Diabetes Treatment and Management
- Diabetes Treatment and Management
- Biomedical Text Mining and Ontologies
- Biomedical Text Mining and Ontologies
- Primary Care and Health Outcomes
- Ethics in Clinical Research
- Ethics in Clinical Research
- Diabetes Treatment and Management
- Primary Care and Health Outcomes
- Drug-Induced Hepatotoxicity and Protection
- Drug-Induced Adverse Reactions
- Antibiotics Pharmacokinetics and Efficacy
- Influenza Virus Research Studies
- Blood Pressure and Hypertension Studies
- SARS-CoV-2 and COVID-19 Research
- Antibiotic Resistance in Bacteria
- Pregnancy and Medication Impact
- SARS-CoV-2 and COVID-19 Research
- Drug-Induced Hepatotoxicity and Protection
- Blood Pressure and Hypertension Studies
- Influenza Virus Research Studies
- Antibiotics Pharmacokinetics and Efficacy
- Drug-Induced Adverse Reactions
- COVID-19 Clinical Research Studies
- Blood Pressure and Hypertension Studies
- Pregnancy and Medication Impact
Keywords (DOAJ)
- molecular pharmacoepidemiology
- the methodology of pharmacoepidemiology
- pharmacovigilance
- pharmacoeconomics
- clinical pharmacology
- epidemiology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ